Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Assertio Holdings Total Long Term Liabilities 2010-2025 | ASRT

Assertio Holdings total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
  
Assertio Holdings Annual Total Long Term Liabilities
(Millions of US $)
2024 $49
2023 $55
2022 $93
2021 $89
2020 $115
2019 $285
2018 $466
2017 $559
2016 $747
2015 $823
2014 $289
2013 $214
2012 $21
2011 $19
2010 $31
2009 $44
Assertio Holdings Quarterly Total Long Term Liabilities
(Millions of US $)
2025-03-31 $49
2024-12-31 $49
2024-09-30 $55
2024-06-30 $55
2024-03-31 $55
2023-12-31 $55
2023-09-30 $73
2023-06-30 $71
2023-03-31 $69
2022-12-31 $93
2022-09-30 $96
2022-06-30 $77
2022-03-31 $89
2021-12-31 $89
2021-09-30 $102
2021-06-30 $103
2021-03-31 $111
2020-12-31 $115
2020-09-30 $125
2020-06-30 $126
2020-03-31 $13
2019-12-31 $285
2019-09-30 $303
2019-06-30 $438
2019-03-31 $452
2018-12-31 $466
2018-09-30 $480
2018-06-30 $489
2018-03-31 $539
2017-12-31 $559
2017-09-30 $598
2017-06-30 $595
2017-03-31 $648
2016-12-31 $747
2016-09-30 $743
2016-06-30 $731
2016-03-31 $727
2015-12-31 $823
2015-09-30 $841
2015-06-30 $841
2015-03-31 $283
2014-12-31 $289
2014-09-30 $363
2014-06-30 $165
2014-03-31 $189
2013-12-31 $214
2013-09-30 $30
2013-06-30 $23
2013-03-31 $23
2012-12-31 $21
2012-09-30 $16
2012-06-30 $17
2012-03-31 $17
2011-12-31 $19
2011-09-30 $19
2011-06-30 $23
2011-03-31 $24
2010-12-31 $31
2010-09-30 $33
2010-06-30 $36
2010-03-31 $40
2009-12-31 $44
2009-09-30 $48
2009-06-30 $51
2009-03-31 $55
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.062B $0.125B
Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc., is based in LAKE FOREST, Ill.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.152B 31.57
Zoetis (ZTS) United States $75.067B 28.01
Takeda Pharmaceutical (TAK) Japan $47.697B 9.49
Daiichi Sankyo, - (DSNKY) Japan $46.849B 23.83
Sandoz Group AG (SDZNY) Switzerland $23.527B 0.00
Merck (MKKGY) Germany $17.005B 12.46
Summit Therapeutics (SMMT) United States $14.653B 0.00
United Therapeutics (UTHR) United States $14.421B 12.76
Shionogi (SGIOY) Japan $14.275B 14.30
Neurocrine Biosciences (NBIX) United States $12.332B 42.24
Orion OYJ (ORINY) Finland $10.083B 27.27
IPSEN (IPSEY) France $10.039B 0.00
Corcept Therapeutics (CORT) United States $7.318B 59.49
Stevanato Group S.p.A (STVN) Italy $7.038B 43.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.086B 0.00
Grifols, S.A (GRFS) Spain $5.995B 0.00
Ionis Pharmaceuticals (IONS) United States $5.609B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.791B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.093B 10.84
Crinetics Pharmaceuticals (CRNX) United States $3.026B 0.00
Hypermarcas (HYPMY) Brazil $2.958B 19.46
BioCryst Pharmaceuticals (BCRX) United States $2.298B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.247B 12.15
NewAmsterdam Pharma (NAMS) Netherlands $2.190B 0.00
Indivior (INDV) United States $1.874B 7.95
Recursion Pharmaceuticals (RXRX) United States $1.858B 0.00
Dyne Therapeutics (DYN) United States $1.590B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.584B 0.00
Evotec AG (EVO) Germany $1.424B 0.00
Ocular Therapeutix (OCUL) United States $1.348B 0.00
Guardian Pharmacy Services (GRDN) United States $1.324B 0.00
ARS Pharmaceuticals (SPRY) United States $1.320B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.093B 21.86
Harrow (HROW) United States $1.054B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Akebia Therapeutics (AKBA) United States $0.969B 0.00
Collegium Pharmaceutical (COLL) United States $0.948B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.913B 0.00
Ardelyx (ARDX) United States $0.871B 0.00
Cronos Group (CRON) Canada $0.737B 0.00
Xeris Biopharma Holdings (XERS) United States $0.697B 0.00
KalVista Pharmaceuticals (KALV) United States $0.686B 0.00
Xencor (XNCR) United States $0.649B 0.00
Liminatus Pharma (LIMN) United States $0.640B 0.00
AleAnna (ANNA) United States $0.608B 0.00
Elite Pharmaceuticals (ELTP) United States $0.595B 0.00
Regulus Therapeutics (RGLS) United States $0.561B 0.00
Relay Therapeutics (RLAY) United States $0.555B 0.00
USANA Health Sciences (USNA) United States $0.541B 11.77
Theravance Biopharma (TBPH) United States $0.539B 0.00
Bioventus (BVS) United States $0.535B 13.56
Verve Therapeutics (VERV) United States $0.511B 0.00
Tourmaline Bio (TRML) United States $0.485B 0.00
Zevra Therapeutics (ZVRA) United States $0.483B 0.00
Oruka Therapeutics (ORKA) United States $0.456B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Altimmune (ALT) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.420B 8.78
Savara (SVRA) United States $0.411B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.375B 10.13
Organogenesis (ORGO) United States $0.365B 0.00
Aquestive Therapeutics (AQST) United States $0.355B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.281B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.68
MediWound (MDWD) Israel $0.234B 0.00
ProKidney (PROK) United States $0.230B 0.00
Esperion Therapeutics (ESPR) United States $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.181B 0.00
Journey Medical (DERM) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.170B 0.00
Lyell Immunopharma (LYEL) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
OmniAb (OABI) United States $0.169B 0.00
Larimar Therapeutics (LRMR) United States $0.158B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.154B 0.00
Avita Medical (RCEL) United States $0.152B 0.00
Aldeyra Therapeutics (ALDX) United States $0.147B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Wellgistics Health (WGRX) United States $0.125B 0.00
Achieve Life Sciences (ACHV) Canada $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Cardiol Therapeutics (CRDL) Canada $0.114B 0.00
Lexeo Therapeutics (LXEO) United States $0.109B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.108B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Unicycive Therapeutics (UNCY) United States $0.093B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.092B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.090B 14.77
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.082B 0.00
Nutriband (NTRB) United States $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.081B 60.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.051B 0.00
Context Therapeutics (CNTX) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Avalo Therapeutics (AVTX) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.037B 0.00
SCYNEXIS (SCYX) United States $0.035B 0.00
Lyra Therapeutics (LYRA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.027B 0.00
Relmada Therapeutics (RLMD) United States $0.027B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Ainos (AIMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
GlycoMimetics (GLYC) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00